Correlation Between Newbury Pharmaceuticals and G5 Entertainment

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Newbury Pharmaceuticals and G5 Entertainment at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Newbury Pharmaceuticals and G5 Entertainment into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Newbury Pharmaceuticals AB and G5 Entertainment publ, you can compare the effects of market volatilities on Newbury Pharmaceuticals and G5 Entertainment and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Newbury Pharmaceuticals with a short position of G5 Entertainment. Check out your portfolio center. Please also check ongoing floating volatility patterns of Newbury Pharmaceuticals and G5 Entertainment.

Diversification Opportunities for Newbury Pharmaceuticals and G5 Entertainment

-0.24
  Correlation Coefficient

Very good diversification

The 3 months correlation between Newbury and G5EN is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Newbury Pharmaceuticals AB and G5 Entertainment publ in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on G5 Entertainment publ and Newbury Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Newbury Pharmaceuticals AB are associated (or correlated) with G5 Entertainment. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of G5 Entertainment publ has no effect on the direction of Newbury Pharmaceuticals i.e., Newbury Pharmaceuticals and G5 Entertainment go up and down completely randomly.

Pair Corralation between Newbury Pharmaceuticals and G5 Entertainment

Assuming the 90 days trading horizon Newbury Pharmaceuticals AB is expected to generate 1.74 times more return on investment than G5 Entertainment. However, Newbury Pharmaceuticals is 1.74 times more volatile than G5 Entertainment publ. It trades about -0.01 of its potential returns per unit of risk. G5 Entertainment publ is currently generating about -0.03 per unit of risk. If you would invest  561.00  in Newbury Pharmaceuticals AB on November 9, 2024 and sell it today you would lose (221.00) from holding Newbury Pharmaceuticals AB or give up 39.39% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

Newbury Pharmaceuticals AB  vs.  G5 Entertainment publ

 Performance 
       Timeline  
Newbury Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Newbury Pharmaceuticals AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
G5 Entertainment publ 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in G5 Entertainment publ are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, G5 Entertainment unveiled solid returns over the last few months and may actually be approaching a breakup point.

Newbury Pharmaceuticals and G5 Entertainment Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Newbury Pharmaceuticals and G5 Entertainment

The main advantage of trading using opposite Newbury Pharmaceuticals and G5 Entertainment positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Newbury Pharmaceuticals position performs unexpectedly, G5 Entertainment can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in G5 Entertainment will offset losses from the drop in G5 Entertainment's long position.
The idea behind Newbury Pharmaceuticals AB and G5 Entertainment publ pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets